Pfizer's Trading Volume Surges 102% to Rank 45th in Market Activity

On May 12, 2025, Pfizer's trading volume reached 17.70 billion, marking a significant increase of 102.07% compared to the previous day, ranking 45th in the day's stock market activity. Pfizer's stock price rose by 3.64%.

Pfizer has announced that it will invest $1 billion in expanding its manufacturing facilities in the United States. This investment is part of the company's strategy to increase its production capacity and meet the growing demand for its products. The expansion is expected to create thousands of new jobs and boost the local economy.

Pfizer's CEO, Albert Bourla, has stated that the company is committed to innovation and will continue to invest in research and development. He emphasized that Pfizer's focus on developing new treatments and vaccines will drive the company's growth in the coming years. The CEO's remarks have been well-received by investors, who see Pfizer as a leader in the pharmaceutical industry.

Pfizer has also announced that it will acquire a biotechnology company specializing in gene therapy. This acquisition is part of Pfizer's strategy to expand its portfolio of innovative treatments. The acquisition is expected to close in the fourth quarter of this year, subject to regulatory approval. The deal is seen as a positive move for Pfizer, as it will strengthen the company's position in the gene therapy market.